http://goldbamboo.com/ Ibritumomab tiuxetan News from GoldBamboo.com en-us © 2005, Gold Bamboo LLC, All Rights Reserved http://goldbamboo.com/news-a162073.html Biogen Idec Inc (Nasdaq: BIIB) announced that new data, presented today at the 47th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, December 10-13, demonstrate that patients may benefit from earlier and consolidated use of ZEVALINâ (Ibritumomab Tiuxetan) radioimmunotherapy in refractory and hard-to-treat cancers, including diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular non-Hodgkin''s lymphoma (FL)... click link for more info. Tue, 27 Dec 2005 06:00 EST http://goldbamboo.com/news-a129179.html According to a University of Pittsburgh Medical Center (UPMC) study, patients with advanced non-Hodgkin's lymphoma (NHL) previously treated with chemotherapy and adult stem cell transplantation can safely tolerate ZevalinTM (ibritumomab tiuxetan), a radiolabeled monoclonal antibody that targets radiation directly to a tumor... click link for more info. Tue, 17 May 2005 03:00 EST